https://www.selleckchem.com/pr....oducts/tucidinostat-
ggest that omalizumab therapy is associated with decreased BAL MMPs concentration in the subgroup of asthma patients. The decline was linked with a reduction in the RBM thickness what might play a beneficial role in airway remodeling. Our data suggest that omalizumab therapy is associated with decreased BAL MMPs concentration in the subgroup of asthma patients. The decline was linked with a reduction in the RBM thickness what might play a beneficial role in airway remodeling. The Stevens-Johnsonsyndrome (SJS) and toxic ep
Like
Comment
Share
